IsoPlexis to Report Third Quarter 2022 Financial Results on November 10, 2022

Rhea-AI Summary

IsoPlexis Corporation (Nasdaq: ISO) will report its third-quarter 2022 financial results on November 10, 2022, before market open. A conference call will follow at 5:30 a.m. PT / 8:30 a.m. ET. The company's platforms provide critical insights into immune cell behavior, aiding in understanding disease progression and treatment efficacy. IsoPlexis has been recognized for innovation by prominent organizations and is utilized by major pharmaceutical companies and leading cancer centers globally.

Positive

• Recognition for innovation by multiple prestigious organizations.
• Widespread usage of the IsoPlexis platform by top pharmaceutical companies and cancer centers.

Negative

• None.

BRANFORD, Conn., Oct. 19, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced it will report financial results for the third quarter 2022 before market open on Thursday, November 10, 2022. Company management will be webcasting a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.

Live audio of the webcast will be available on the “Investors” section of the company website at: www.isoplexis.com. The webcast will be archived and available for replay after the event.

About IsoPlexis

IsoPlexis is empowering labs to leverage the cells and proteome changing the course of human health. Its platforms provide insights into how multi-functional immune cells communicate and respond, assisting researchers in understanding and predicting disease progression, treatment resistance and therapeutic efficacy.

IsoPlexis has been named Top Innovation or Design by The Scientist Magazine, Fierce, BIG Innovation, Red Dot and multiple others. The IsoPlexis platform is used globally by researchers, including those at the top 15 global pharmaceutical companies by revenue and 78% of leading U.S. comprehensive cancer centers.

Investor Contact
investors@isoplexis.com

Press Contact
press@isoplexis.com

FAQ

When will IsoPlexis report its third-quarter 2022 financial results?

IsoPlexis will report its third-quarter 2022 financial results on November 10, 2022.

What time will the IsoPlexis conference call take place?

The conference call for IsoPlexis will begin at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.

Where can I listen to the IsoPlexis earnings call?

The IsoPlexis earnings call will be available via webcast on the company's website in the 'Investors' section.

What is the significance of IsoPlexis's platform?

IsoPlexis's platform provides insights into immune cell interactions, which are crucial for understanding disease and treatment outcomes.

Which organizations have recognized IsoPlexis for innovation?

IsoPlexis has received accolades from The Scientist Magazine, Fierce, BIG Innovation, and Red Dot, among others.